HIV Diagnostics Market Set Close To USD 4.48 billion From 2024
HIV Diagnostics Market is anticipated to reach USD 4.48 billion by 2022. The human immunodeficiency virus (HIV) leads to Acquired Immuno Deficiency Syndrome (AIDS). HIV attacks the immune system; thereby making one vulnerable to hoards of diseases. The factors that propel the growth of the HIV Diagnostics industry include growing number of blood transfusions and blood donations, prevalence of HIV/AIDS worldwide, assistance offered by point-of-care instruments & kits, and growing consciousness about HIV/AIDS and rising administration initiatives. On the other hand, there are factors that may hamper the growth of the market including absence of acceptable testing labs, and restrictions of laboratory-based testing. HIV Diagnostics Market is anticipated to grow at a significant CAGR of 9.5% in the upcoming period as the scope, product types, and its applications are increasing across the globe. Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry